FDA Warnings Target Companies US-Wide For Selling CBD Products That Violate Federal Law

27 Nov 2019

CHART: The agency sent out 15 warning letters on 25 November, citing companies in 10 states for selling unapproved and misbranded CBD drug products in the guise of dietary supplements and cosmetics.

Vintage inscription made by old typewriter, warning

FDA Warnings Target Companies US-Wide For Selling CBD Products That Violate Federal Law

More from Regulation

More from Policy & Regulation